ZAPI GROUP Launches New Charger Platform
ZAPI GROUP, a global leader in electrification, today announced a new comprehensive charging platform with the launch of Zivan srl (Zivan)’s new charger, CT3.3 Compact Titan. The first model of Zivan’s charger is a 3.3 kilowatt (kW) solution that builds on the success of the first generation of the charger adopted by leading original equipment manufacturers (OEMs) in Europe. The new charger is also the result of a design partnership with Delta-Q Technologies Corp (Delta-Q) leveraging its XV3300 charger announced last year.
The ZAPI GROUP charger platform contains both Zivan’s CT3.3 Compact Titan and Delta-Q’s XV3300 product models, offering OEMs around the world flexible and robust charging options. Zivan and Delta-Q’s collaboration aims to provide a power electronics platform that both brands can tailor to suit different markets and customer requirements. As charging experts within ZAPI GROUP, Zivan and Delta-Q designed the charger’s hardware, software and mechanical durability for use on traditional and emerging electrification markets, such as construction and industrial OEMs transitioning their products to electric drive.
“We made a significant leap forward in power density with this new platform,” said Steve Blaine Co-CEO & Executive VP, Engineering & Quality with Delta-Q. “Our solutions will make homologating into OEM designs much easier.”
The first 3.3 kW chargers as part of ZAPI GROUP’s charging platform meet customers’ needs for electrified applications across global markets. The new products maintain Zivan and Delta-Q’s leadership standards for high-quality ruggedized chargers, purpose-built for the most demanding applications.
“We are excited to bring together key charger hardware and software design capabilities from our engineering teams in Delta-Q and Zivan,” said Simone Paterlini, General Manager with Zivan. “This collaboration demonstrates ZAPI GROUP’s commitment to innovation, electrification and driving results for customers.”
Both products will be displayed at the bauma trade fair this October in the ZAPI GROUP booth (Hall A4, Booth 115). This event is known as the largest tradeshow in the world for construction equipment technology. It’s held every 3 years and sees over half a million attendees. ZAPI GROUP will exhibit samples and provide demos of how the chargers can be personalized with different housing designs, embedded software, integrated features, together with manufacturing and logistics options.
“We are pleased with the growth we are seeing from our charger businesses and will continue to invest in Delta-Q and Zivan to pace the accelerating electrification demands from the construction and industrial equipment sectors,” said Mr. Federico Gatti, Managing Director of the ZAPI GROUP.
About ZAPI GROUP
ZAPI GROUP is engineering the transition to an all-electric future with a highly integrated product portfolio including motion controllers, electric motors, and high-frequency battery chargers for application in electric and hybrid vehicles. As a global electrification leader with deep systems experience, leading innovations, and an obsession with driving customers' success, ZAPI GROUP now counts more than 1500 employees worldwide with total annual revenue of over 600 million US dollars. For more information, visit www.zapigroup.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221024005212/en/
Contact information
AnnMarie Carson, Communiqué PR
Phone: (206) 282-4923
ZapiGroupPR@communiquepr.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 10:15:00 EEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 10:00:00 EEST | Press release
Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vice President, Skechers Technical Performance Division. “An evolution of our legacy in running, Skechers AERO was d
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 10:00:00 EEST | Press release
Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP and Optical Transport, Mobile Networks, Mobile Services, and Data Centres. “Network X is more than a conference—it
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 08:00:00 EEST | Press release
4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P004. “Enrolling our first patient is a pivotal step toward rewriting the treatment paradigm for knee osteoarthritis,” said Professor Francis Berenbaum, MD, PhD, Chief Medical Officer at 4Moving Biotech. “Almost 600 million people live with OA, yet no disease-modifying therapy has been done to patients. B
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 20:06:00 EEST | Press release
Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The company’s global headquarters includes WPC certified test equipment and state-of-the-art test labs dedicated to full product lifecycle validatio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom